Pricing Log in Create free account
Saturday 17 October 2026 Export CCM’s income statement to Excel — free account

Concord Medical Services Holdings Limited

CCM Healthcare Medical Care Facilities

Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.

3.63 0.08 −2.16%
Market cap
$10.5M
P/E
0.0×
Fwd P/E
−4.4×
Dividend yield
—
F-score
6/9
Altman Z
−1.20
Beneish M
−5.04
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 45.88%

Capital & Financial Ratios $m

Market Cap 10.46
Revenue 155.78
Net Income (53.70)
Free Cash Flow 67.56
Net Debt 395.45
Current Ratio 0.42 (below 1: weak)
Debt/Equity 1.76
P/E ratio 0.00
Fwd P/E (4.39) (negative: loss-making)
P/S ratio 0.10
P/B ratio 0.07
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth (100.00%) (below 0%: weak)
Next 5Y EPS Growth 20.00% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 2.6×, against a ten-year median of 2.6×; over the ten years it ranged from 0.8× in 2018 to 7.8× in 2021.
P/S against its own 10 years 0.92%
10-year low 10-year high
P/B against its own 10 years 2.02%
10-year low 10-year high
EV/Sales against its own 10 years 51.35%
10-year low 10-year high
EV/FCF against its own 10 years 65.28%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2020 Powerpack
2019 Powerpack
2018 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2022 2023 2024 2025
Cash 23 13 51 43
Receivables 19 10 7 6
Inventory 12 6 5 7
Other — — — —
110 87 135 135
2022 2023 2024 2025
Payables 21 18 27 17
ST’ Debt 50 102 52 79
Other 61 0 — —
163 275 291 279

Compound Annual Growth %

10y 5y 3y
Sales (3.62%) 14.02% (1.28%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 1.80% 0.00% (3.26%)

Revenue $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — 66
’24 — — — — 53
’23 — — — — 76
’22 — — — — 68
’21 — — — — 76
’20 — — — — 34
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (29)
’24 — — — — (54)
’23 — — — — (39)
’22 — — — — (31)
’21 — — — — (56)
’20 — — — — (35)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (36)
’24 — — — — (111)
’23 — — — — (55)
’22 — — — — (63)
’21 — — — — (70)
’20 — — — — (62)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 — — — — —
’25 — — — — (3.04)
’24 — — — — (9.67)
’23 — — — — (9.60)
’22 — — — — (16.20)
’21 — — — — (29.40)
’20 — — — — (23.40)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

5
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 35.10 32.20 24.60 18.50 11.30 18.50 11.50 9.20 3.80 3.54

Analyst estimates 2026–2028

Powerpack
High 51.30 49.60 42.00 36.00 58.90 47.00 23.80 19.90 26.70 10.77
People
People Employees 739 583 584 738 851 972 918 727 595 610
Revenue/emp, $m 0.09 0.09 0.05 0.04 0.04 0.08 0.07 0.10 0.09 0.11
Income, $m
Income, $m Revenue 66 51 28 28 34 76 68 76 53 66
Gross margin, % 37.03 29.61 10.35 (7.98) 5.87 (11.72) (32.28) (14.26) (20.62) 5.61
EBT (29) (39) (33) (56) (68) (83) (122) (78) (92) (53)
EBT margin, % (44.96) (76.71) (117.99) (197.15) (198.05) (108.98) (177.91) (103.39) (174.39) (81.07)
Net income (38) (44) (38) (51) (62) (82) (111) (75) (89) (54)
Depreciation 19 15 8 8 12 16 19 18 18 21
Per share, $
Per share, $ Revenue 15.05 11.73 6.40 6.56 7.82 17.44 15.67 17.33 12.04 15.08
Earnings (8.70) (10.20) (12.00) (18.30) (23.40) (29.40) (16.20) (9.60) (9.67) (3.04)
Cash flow (2.58) 0.95 (1.29) (6.46) (8.06) (12.91) (7.19) (8.91) (12.47) (6.61)
Capex (2.25) (1.75) (1.74) (5.42) (6.17) (3.08) (7.25) (3.77) (12.89) (1.60)
Free cash flow (4.83) (0.80) (3.03) (11.89) (14.23) (15.99) (14.44) (12.68) (25.36) (8.21)
Book value 40.74 35.98 18.56 (0.67) (17.99) (33.66) 66.90 56.33 50.74 60.57
Shares, m 4 4 4 4 4 4 4 4 4 4
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S 2.18 1.63 2.26 2.03 1.97 0.82 0.55 0.32 0.15 0.11
P/B 0.93 0.70 2.46 0.00 0.00 0.00 0.00 0.18 0.09 0.07
EV/Sales 1.74 1.20 2.39 6.45 7.00 4.53 3.60 2.57 2.51 2.65
EV/FCF 2.39 1.64 2.45 5.52 6.34 7.23 7.70 5.92 5.79 6.10
Cash, $m
Cash, $m Operating cash flow (11) 4 (6) (28) (35) (56) (31) (39) (54) (29)
Capex (10) (8) (8) (24) (27) (13) (32) (16) (56) (7)
Free cash flow (21) (3) (13) (52) (62) (70) (63) (55) (111) (36)
Balance, $m
Balance, $m Working capital 35 0 52 (50) 25 (35) (52) (188) (156) (145)
Total debt 79 99 79 192 321 367 408 383 422 431
Net debt (32) (6) (53) 176 265 342 385 370 371 389
Shareholders’ equity 177 156 81 (3) (79) (147) 292 246 222 265
Returns, %
Returns, % ROA (7.39) (8.76) (8.71) (12.36) (14.31) (14.35) (7.68) (4.87) (4.76) (1.43)
ROIC (10.42) (13.52) (99.09) (22.69) (16.25) (23.05) (7.02) (6.62) (7.69) (3.58)
ROE (18.92) (26.21) (44.19) (204.60) 251.88 114.14 (97.79) (15.58) (18.06) (5.46)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2016

Charts ten years each

Concord Medical Services Holdings Limited vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CCEL Cryo-Cell International Inc. $29.4M — (loss-making) 43.8× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00%
AMS American Shared Hospital Services $8.4M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
CANOQ Cano Health, Inc. $6.6M — (loss-making) — −21.05% (below 0%: shrinking) n/m −43.68% (below 0%: shrinking) 100.00% (16.23%) Compare
MODVQ ModivCare Inc. $6.2M — (loss-making) — (loss-making) −3.18% (below 0%: shrinking) n/m −3,767.70% (below 0%: shrinking) 14.06% (1.78%) Compare
BMGL Basel Medical Group Ltd $6.2M — — — — — — — Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
Median of peers $7.5M — 8.3× −0.02% — −58.37% 31.50% (1.78%)

All 55 Medical Care Facilities stocks →

Concord Medical Services Holdings Limited (CCM) key facts

  • Strength: Concord Medical Services Holdings Limited’s revenue for fiscal 2025 (year ended December 2025) was $65.9 million, up 25.2% from fiscal 2024.
  • Concord Medical Services Holdings Limited (CCM) is a Medical Care Facilities company in the Healthcare sector, traded in the US as an ADR.
  • As of October 16, 2026, CCM traded at $3.63, a market capitalization of $10.5 million.
  • Return on equity was −5.46% and debt-to-equity 1.76.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is −1.20 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Concord Medical Services Holdings Limited (CCM) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/CCM · Data as of Mar 31, 2016 · For information only; not investment advice. · © 2026 stockrow.com